Search Results - "Farr, Susan A."
-
1
The role of amyloid-beta in the regulation of memory
Published in Biochemical pharmacology (15-04-2014)“…In this review there is evidence that amyloid-beta peptide is a memory enhancer at physiological (picomolar) concentrations. Pathological overproduction of…”
Get full text
Journal Article -
2
The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease
Published in Current pharmaceutical design (01-03-2012)“…The senescence accelerate mouse P8 (SAMP8) is an excellent model of early learning and memory problems. A number of studies have shown that it has cholinergic…”
Get more information
Journal Article -
3
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease
Published in Journal of Alzheimer's disease (26-06-2015)“…Recent studies indicate that glucagon-like peptide 1 (GLP-1) receptor agonists, currently used in the management of type 2 diabetes, exhibit neurotrophic and…”
Get more information
Journal Article -
4
Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment
Published in The Journal of clinical investigation (01-09-2022)“…Cancer-related cognitive impairment (CRCI) is a major neurotoxicity affecting more than 50% of cancer survivors. The underpinning mechanisms are mostly…”
Get full text
Journal Article -
5
Alzheimer Disease
Published in Clinics in geriatric medicine (01-11-2018)“…Alzheimer disease is due to increased amyloid-β coupled with low progranulin. Several brain imaging techniques are helpful in the diagnosis. Drugs available…”
Get full text
Journal Article -
6
Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury
Published in Journal of neuroinflammation (12-11-2020)“…Abstract Background Traumatic brain injury (TBI) is a common pathological condition that presently lacks a specific pharmacological treatment. Adenosine levels…”
Get full text
Journal Article -
7
Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition
Published in Journal of Alzheimer's disease (03-08-2015)“…Intranasal insulin has shown efficacy in patients with Alzheimer's disease (AD), but there are no preclinical studies determining whether or how it reaches the…”
Get more information
Journal Article -
8
Targeting nonsense-mediated RNA decay does not increase progranulin levels in the Grn R493X mouse model of frontotemporal dementia
Published in PloS one (09-03-2023)“…A common cause of frontotemporal dementia (FTD) are nonsense mutations in the progranulin (GRN) gene. Because nonsense mutations activate the nonsense-mediated…”
Get full text
Journal Article -
9
Obesity and Hypertriglyceridemia Produce Cognitive Impairment
Published in Endocrinology (Philadelphia) (01-05-2008)“…Obesity is associated with cognitive impairments. Long-term mechanisms for this association include consequences of hyperglycemia, dyslipidemia, or other…”
Get full text
Journal Article -
10
Effect of botanical extracts containing carnosic acid or rosmarinic acid on learning and memory in SAMP8 mice
Published in Physiology & behavior (15-10-2016)“…Abstract Oxidative damage is one of the hallmarks of the aging process. The current study evaluated effects of two proprietary antioxidant-based ingredients,…”
Get full text
Journal Article -
11
Association Between Metformin Initiation and Incident Dementia Among African American and White Veterans Health Administration Patients
Published in Annals of family medicine (01-07-2019)“…AbstractPurposeAfrican American patients are more likely to experience cognitive decline after type 2 diabetes mellitus onset than white patients. Metformin…”
Get full text
Journal Article -
12
Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's disease
Published in PloS one (11-04-2019)“…Alzheimer's disease currently lacks treatment options that effectively reverse the biological/anatomical pathology and cognitive deficits associated with the…”
Get full text
Journal Article -
13
Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity
Published in Journal of controlled release (10-10-2017)“…Leptin is an adipocyte-secreted hormone that is delivered via a specific transport system across the blood-brain barrier (BBB) to the brain where it acts on…”
Get full text
Journal Article -
14
Ghrelin controls hippocampal spine synapse density and memory performance
Published in Nature neuroscience (01-03-2006)“…The gut hormone and neuropeptide ghrelin affects energy balance and growth hormone release through hypothalamic action that involves synaptic plasticity in the…”
Get full text
Journal Article -
15
Extra virgin olive oil improves learning and memory in SAMP8 mice
Published in Journal of Alzheimer's disease (01-01-2012)“…Polyphenols are potent antioxidants found in extra virgin olive oil (EVOO); antioxidants have been shown to reverse age- and disease-related learning and…”
Get more information
Journal Article -
16
Targeting the A3 adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice
Published in Acta neuropathologica communications (29-01-2022)“…Abstract Cisplatin is used to combat solid tumors. However, patients treated with cisplatin often develop cognitive impairments, sensorimotor deficits, and…”
Get full text
Journal Article -
17
Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism
Published in Redox biology (01-12-2021)“…Adropin is a highly-conserved peptide that has been shown to preserve endothelial barrier function. Blood-brain barrier (BBB) disruption is a key pathological…”
Get full text
Journal Article -
18
Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins
Published in The Journal of pharmacology and experimental therapeutics (01-05-2008)“…Galanin-like peptide (GALP) shows potential as a therapeutic in the treatment of obesity and related conditions. In this study, we compared the uptake by brain…”
Get more information
Journal Article -
19
Alzheimer Mythology: A Time to Think Out of the Box
Published in Journal of the American Medical Directors Association (01-09-2016)Get full text
Journal Article -
20
Somatostatin receptor subtype-4 agonist NNC 26-9100 mitigates the effect of soluble Aβ42 oligomers via a metalloproteinase-dependent mechanism
Published in Brain research (03-07-2013)“…Abstract Soluble amyloid-β peptide (Aβ) oligomers have been hypothesized to be primary mediators of Alzheimer's disease progression. In this regard, reduction…”
Get full text
Journal Article